Raxibacumab (ABthrax) is a human IgG1 monoclonal antibody against Bacillus anthracis protective antigen (PA). Raxibacumab blocks the toxins deleterious effects by preventing binding of the protective antigen component of the anthrax toxin to its receptors in host cells, thereby blocking the toxins deleterious effects. Raxibacumab can be used for anti-anthrax research[1][2].
Molekulargewicht:
(142.96 kDa)
Reinheit:
98.88
CAS Nummer:
[565451-13-0]
Target-Kategorie:
Bacterial
Anwendungsbeschreibung:
MCE Product type: Inhibitory Antibodies
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten